Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy.
Year: 2000
Type: article
Source: PubMed
Institution: University of California, Los Angeles
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W35282639
